GlassScriptPhysician profile
Ashika S Patel
NPI 1336915727
$5,531.11
in general payments reported to CMS, 2019-2025
21 companies · $2,223 in 2025
The $2,223 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,308 · 2025: $2,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,277 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,277.14 |
| Education | $253.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $788.39 | 2024-2025 | |
| Ucb, INC. | $616.84 | 2024-2025 | Bimzelx |
| Incyte Corporation | $609.70 | 2024-2025 | Opzelura |
| Leo Pharma INC. | $531.22 | 2024-2025 | Adbry, Anzupgo |
| Journey Medical Corporation | $495.72 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $389.08 | 2024-2025 | |
| Genzyme Corporation | $377.48 | 2024-2025 | |
| Janssen Biotech, INC. | $337.12 | 2025 | Tremfya, Simponi, Simponi Aria |
| Arcutis Biotherapeutics, INC. | $311.03 | 2024-2025 | Zoryve |
| Lilly USA, LLC | $264.46 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $160.03 | 2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $147.63 | 2025 | |
| Galderma Laboratories, L.P. | $141.89 | 2025 | Nemluvio |
| Pfizer INC. | $115.07 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $76.62 | 2024-2025 | Cabtreo, Siliq, Jublia |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $50.00 | 2024 | Otezla |
| Botanix Sb INC | $35.51 | 2025 | Sofdra |
| Regeneron Healthcare Solutions, INC. | $34.20 | 2025 | Dupixent, Libtayo |
| Dermavant Sciences, INC. | $26.51 | 2024 | Vtama |
| Strata Skin Sciences, INC. | $14.13 | 2025 | Xtrac |
| Mayne Pharma Commercial LLC | $8.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashika Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.